As of December 2024, Aurobindo Pharma has a market cap of $8.56B. This makes Aurobindo Pharma the world's 1762th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $7.02B | -6.16% |
2023 | $7.48B | 147.32% |
2022 | $3.02B | -40.31% |
2021 | $5.07B | -20.29% |
2020 | $6.35B | 101.66% |
2019 | $3.15B | -37.67% |
2018 | $5.06B | 6.54% |
2017 | $4.75B | 2.79% |
2016 | $4.62B | -23.59% |
2015 | $6.04B | 54.26% |
2014 | $3.92B | 189.13% |
2013 | $1.35B | 107.39% |
2012 | $653.21M | 122.43% |
2011 | $293.67M | -67.60% |
2010 | $906.29M | 44.09% |
2009 | $628.97M | 441.48% |
2008 | $116.16M | -68.98% |
2007 | $374.51M | -23.09% |
2006 | $486.94M | 71.91% |
2005 | $283.25M | 25.70% |
2004 | $225.35M | -24.05% |
2003 | $296.70M | 310.94% |
2002 | $72.20M | -8.56% |
2001 | $78.96M | -54.10% |
2000 | $172.05M | -59.59% |
1999 | $425.78M | 574.62% |
1998 | $63.11M | 68.51% |
1997 | $37.45M | 62.09% |
1996 | $23.11M | - |